R
Ronald L. Gibson
Researcher at University of Washington
Publications - 146
Citations - 13122
Ronald L. Gibson is an academic researcher from University of Washington. The author has contributed to research in topics: Cystic fibrosis & Pseudomonas aeruginosa. The author has an hindex of 54, co-authored 127 publications receiving 11961 citations. Previous affiliations of Ronald L. Gibson include Stanford University & Lucile Packard Children's Hospital.
Papers
More filters
Journal ArticleDOI
Pathophysiology and management of pulmonary infections in cystic fibrosis.
TL;DR: This comprehensive State of the Art review summarizes the current published knowledge base regarding the pathophysiology and microbiology of pulmonary disease in cystic fibrosis and potential future therapies.
Journal ArticleDOI
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Julia Emerson,Julia Emerson,Margaret Rosenfeld,Margaret Rosenfeld,Sharon McNamara,Bonnie W. Ramsey,Bonnie W. Ramsey,Ronald L. Gibson,Ronald L. Gibson +8 more
TL;DR: A registry‐based study to determine prognostic indicators of 8‐year mortality and morbidity in young children with cystic fibrosis (CF) and clinical outcomes in 1998 is conducted.
Journal ArticleDOI
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Jane L. Burns,Ronald L. Gibson,Sharon McNamara,Darlene Yim,Julia Emerson,Margaret Rosenfeld,Peter Hiatt,Karen McCoy,Robert G. Castile,Arnold L. Smith,Bonnie W. Ramsey +10 more
TL;DR: Genotypic and phenotypic changes in P. aeruginosa from oropharynx and bronchoalveolar lavage fluid in a cohort of 40 CF patients during the first 3 years of life suggest infection occurs early in CF and may be intermittent or undetectable by culture.
Journal ArticleDOI
Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
Bonnie W. Ramsey,Henry L. Dorkin,Jay D. Eisenberg,Ronald L. Gibson,I R Harwood,Richard M. Kravitz,D V Schidlow,Robert W. Wilmott,S J Astley,M A McBurnie +9 more
TL;DR: The short-term aerosol administration of a high dose of tobramycin in patients with clinically stable cystic fibrosis is an efficacious and safe treatment for endobronchial infection with P. aeruginosa.
Journal ArticleDOI
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa
Lucas R. Hoffman,Eric Déziel,David A. D'Argenio,François Lépine,Julia Emerson,Sharon McNamara,Ronald L. Gibson,Bonnie W. Ramsey,Samuel I. Miller +8 more
TL;DR: In this paper, the authors show that suppression of S. aureus respiration by a 4-hydroxy-2-heptylquinoline-Noxide (HQNO) exoproduct, 4-H2HNoxide, protects Pseudomonas aeruginosa during coculture from killing by commonly used aminoglycoside antibiotics such as tobramycin.